| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $108K | +14.6% | +746.8% |
| R&D Expense | $165K | +60.2% | -22.2% |
| SG&A Expense | $579K | +5.8% | -28.1% |
| Operating Income | -$745K | -12.6% | +34.1% |
| Net Income | -$733K | -14.1% | +34.7% |
| EPS (Basic) | -$0.16 | -14.3% | +60.0% |
| EPS (Diluted) | -$0.16 | -14.3% | +60.0% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.2M | -36.3% | +124.2% |
| Accounts Receivable | $7K | -30.4% | — |
| Current Assets | $1.3M | -30.1% | -7.9% |
| Total Assets | $2.0M | -23.0% | -6.5% |
| Current Liabilities | $490K | +14.5% | -44.9% |
| Stockholders' Equity | $1.5M | -30.4% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.0M | -149.4% | — |
| Investing Cash Flow | -$131K | -49.8% | — |
| +20.9% |